JESSICA RIFE: Open Payments
NPI 1538734181 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 11 payments from 7 companies in 2025. Trend: 2023 $65 · 2024 $135 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $51 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| Novo Nordisk Inc | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Medtronic, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: Veozah, GARDASIL 9, XIFAXAN, MINIMED 780G, MOUNJARO, AIRSUPRA, Wegovy, Ozempic.
Industry payments across FL — which companies pay providers there.
